Viral hepatitis and liver infections remain a significant global health concern despite advances in prevention and treatment. Chronic viral hepatitis can lead to progressive liver disease, cirrhosis, and hepatocellular carcinoma if left untreated. Improved screening, vaccination programs, and highly effective antiviral therapies have dramatically changed disease outcomes. However, challenges remain in access to care, early diagnosis, and managing co-infections. This topic highlights advances in antiviral therapy, public health strategies, and global efforts aimed at disease elimination, while addressing emerging challenges in liver infections and long-term liver health.
Title : Early and late evaluation of esophageal mucosectomy in surgical treatment of advanced esophageal achalasia
Jose Luis Braga De Aquino, Pontifical Catholic University of Campinas, Brazil
Title : How epigastric impedance would radically change gastric medicine
John Andrew Sutton, Invention City, United States
Title : Nanoemulsions as a strategy to enhance gastrointestinal bioavailability and bioactivity of lipid based nutraceuticals
Pubali Dhar, University of Calcutta, India
Title : Professional dining and health
Yaffa Machnes, Bar-Ilan University, Israel
Title : Sickle cell liver disease: A multidisciplinary hemato-hepatology approach
Bandar Aljudaibi, King Faisal Specialists Hospital and Research Centre, Saudi Arabia
Title : From the birth of atoms to life: Iodine and caesium, angels and demons of evolutionary biology, in pancreatic cancer and diabetes
Venturi Sebastiano, Department of Public Health of Romagna, Italy